Andrea Rosner

1.2k total citations
16 papers, 929 citations indexed

About

Andrea Rosner is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Andrea Rosner has authored 16 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Andrea Rosner's work include Wnt/β-catenin signaling in development and cancer (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cancer Cells and Metastasis (3 papers). Andrea Rosner is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cancer Cells and Metastasis (3 papers). Andrea Rosner collaborates with scholars based in United States, Germany and Slovakia. Andrea Rosner's co-authors include Robert D. Cardiff, Michaël Baumann, Ala Yaromina, Daniel Zips, Xin Xu, Esther Landesman‐Bollag, David C. Seldin, Verena Quennet, Wolfgang Mueller‐Klieser and Stefan Walenta and has published in prestigious journals such as Cancer Research, Oncogene and American Journal Of Pathology.

In The Last Decade

Andrea Rosner

15 papers receiving 923 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrea Rosner United States	12	569	341	310	122	118	16	929
Changxian Shen United States	17	684 1.2×	296 0.9×	288 0.9×	286 2.3×	167 1.4×	38	1.2k
Carlo Gatti Italy	14	551 1.0×	383 1.1×	325 1.0×	102 0.8×	112 0.9×	30	896
Thomas Waerner Germany	10	636 1.1×	306 0.9×	150 0.5×	130 1.1×	59 0.5×	13	866
J.J.T.M. Heuvel Netherlands	16	399 0.7×	401 1.2×	444 1.4×	68 0.6×	82 0.7×	22	886
Norman Chan Canada	15	912 1.6×	672 2.0×	414 1.3×	88 0.7×	295 2.5×	16	1.3k
Michelle A. Gadd United States	10	482 0.8×	437 1.3×	426 1.4×	80 0.7×	104 0.9×	15	1.0k
Saori Fujiwara Japan	18	492 0.9×	268 0.8×	384 1.2×	92 0.8×	122 1.0×	34	845
Gary Box United Kingdom	19	646 1.1×	421 1.2×	241 0.8×	190 1.6×	141 1.2×	36	1.2k
Massimiliano Cariati United Kingdom	10	313 0.6×	453 1.3×	194 0.6×	71 0.6×	90 0.8×	21	784
Frank Mross Switzerland	3	521 0.9×	515 1.5×	362 1.2×	79 0.6×	118 1.0×	7	1.0k

Countries citing papers authored by Andrea Rosner

Since Specialization

Citations

This map shows the geographic impact of Andrea Rosner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Rosner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Rosner more than expected).

Fields of papers citing papers by Andrea Rosner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Rosner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Rosner. The network helps show where Andrea Rosner may publish in the future.

Co-authorship network of co-authors of Andrea Rosner

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Rosner. A scholar is included among the top collaborators of Andrea Rosner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Rosner. Andrea Rosner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Rosner, Andrea, Steffen Jähn, & Katja Preiß. (2022). False-positive blood group A in the bedside pre-transfusion compatibility test. Deutsches Ärzteblatt international. 119(49). 850–850.

Schetelig, Johannes, Falk Heidenreich, Martin Kolditz, et al.. (2021). Risk Factors for a Severe Course of COVID-19 in Persons Aged 18 to 61. Deutsches Ärzteblatt international. 118(16). 288–289. 3 indexed citations

Rosenkranz, Eliot R., Holger Schirutschke, Cedric A. Quick, et al.. (2017). Comparing the efficacy of three techniques to reduce isoagglutinin titers in AB0 incompatible kidney transplant recipients. Atherosclerosis Supplements. 30. 253–256. 5 indexed citations

Rosner, Andrea, et al.. (2014). Methodological and clinical aspects of alloimmunization after granulocyte transfusion in patients undergoing allogeneic stem cell transplantation. Tissue Antigens. 85(2). 93–103. 4 indexed citations

Menschikowski, Mario, et al.. (2013). Plasma Levels of Phospholipase A2-IIA in Patients with Different Types of Malignancies: Prognosis and Association with Inflammatory and Coagulation Biomarkers. Pathology & Oncology Research. 19(4). 839–846. 33 indexed citations

Yaromina, Ala, Marie N. Krause, Howard D. Thames, et al.. (2007). Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation. Radiotherapy and Oncology. 83(3). 304–310. 122 indexed citations

Quennet, Verena, Ala Yaromina, Daniel Zips, et al.. (2006). Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice. Radiotherapy and Oncology. 81(2). 130–135. 151 indexed citations

Yaromina, Ala, Daniel Zips, Howard D. Thames, et al.. (2006). Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: The need for a multivariate approach in biomarker studies. Radiotherapy and Oncology. 81(2). 122–129. 83 indexed citations

Yaromina, Ala, Tobias Hölscher, Wolfgang Eicheler, et al.. (2005). Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?. Radiotherapy and Oncology. 76(2). 206–212. 36 indexed citations

10.

Farago, Marganit, Isabel Domínguez, Esther Landesman‐Bollag, et al.. (2005). Kinase-Inactive Glycogen Synthase Kinase 3β Promotes Wnt Signaling and Mammary Tumorigenesis. Cancer Research. 65(13). 5792–5801. 129 indexed citations

11.

Nguyen, Anthony V., Andrea Rosner, Tatjana Milovanović, et al.. (2005). Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression. International Journal of Oncology. 27(4). 949–56. 43 indexed citations

12.

Jessen, Katayoun A., Clifford G. Tepper, Juliana Karrim, et al.. (2004). Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin. Breast Cancer Research. 6(3). R157–69. 44 indexed citations

13.

Cardiff, Robert D., Andrea Rosner, Michael Hogarth, et al.. (2004). Validation: The New Challenge for Pathology. Toxicologic Pathology. 32(1_suppl). 31–39. 26 indexed citations

14.

Rosner, Andrea, Keiko Miyoshi, Esther Landesman‐Bollag, et al.. (2002). Pathway Pathology. American Journal Of Pathology. 161(3). 1087–1097. 145 indexed citations

15.

Miyoshi, Keiko, Andrea Rosner, Masahiro Nozawa, et al.. (2002). Activation of different Wnt/β-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Oncogene. 21(36). 5548–5556. 90 indexed citations

16.

Chatterjee, Gouri, Andrea Rosner, Yi Han, et al.. (2002). Acceleration of Mouse Mammary Tumor Virus-Induced Murine Mammary Tumorigenesis by a p53172H Transgene. American Journal Of Pathology. 161(6). 2241–2253. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact